A novel gene expression signature in peripheral blood mononuclear cells for early detection of colorectal cancer
Alimentary Pharmacology & Therapeutics2014Vol. 39(5), pp. 507–517
Citations Over TimeTop 17% of 2014 papers
Cristina Nichita, Laura Ciarloni, Sylvain Monnier‐Benoit, Sahar Hosseinian, Gian Dorta, Curzio Rüegg
Abstract
This pilot study demonstrates the potential of developing a minimally invasive, accurate test to screen patients at average risk for colorectal cancer, based on gene expression analysis of peripheral blood mononuclear cells obtained from a simple blood sample.
Related Papers
- → Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype(2006)390 cited
- → A pathway-based gene signature correlates with therapeutic response in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia(2010)12 cited
- → Significance of fecal hemoglobin concentration for predicting risk of colorectal cancer after colonoscopy(2020)3 cited
- A clinical analysis and evaluation of in 360 cases with one-man colonoscopy(2008)
- → Transparent cap‐assisted, water‐exchange colonoscopy in previous incomplete difficult colonoscopy patients: A retrospective study(2020)